SOD3 decreases ischemic injury derived apoptosis through phosphorylation of Erk1/2, Akt, and Foxo3a

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Laatikainen, Lilja E ^a   Incoronato, Mariarosaria ^b   Castellone, Maria Domenica ^c   Laurila, Juha P ^a   Santoro, Massimo ^c   Laukkanen, Mikko O ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b IRCCS SDN   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; EXTRACELLULAR SUPEROXIDE DISMUTASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR FKHRL1; FORKHEAD TRANSCRIPTION FACTOR; FOXO3A PROTEIN, RAT; MITOGEN ACTIVATED PROTEIN KINASE; SOD3 PROTEIN, RAT; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; GENE EXPRESSION REGULATION; HINDLIMB; LIMB ISCHEMIA; MALE; MUSCLE ISCHEMIA; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CELL STRAIN 3T3; ENZYMOLOGY; FISCHER 344 RAT; ISCHEMIA; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION;

ANIMALIA; RATTUS;

ANIMALS; APOPTOSIS; CELL SURVIVAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FORKHEAD TRANSCRIPTION FACTORS; ISCHEMIA; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; NIH 3T3 CELLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED F344; SUPEROXIDE DISMUTASE;

EID: 80052312525     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024456     Document Type: Article

References (35)

1. Fridovich I, (1975) Superoxide dismutases. Annu Rev Biochem 44: 147-159.
2. Marklund SL, (1982) Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A 79: 7634-7638.
3. Oshikawa J, Urao N, Kim HW, Kaplan N, Razvi M, et al. (2010) Extracellular SOD-derived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice. PLoS One 5: e10189.
4. Landmesser U, Merten R, Spiekermann S, Buttner K, Drexler H, et al. (2000) Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 101: 2264-2270.
5. Laukkanen MO, Kivela A, Rissanen T, Rutanen J, Karkkainen MK, et al. (2002) Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta. Circulation 106: 1999-2003.
6. Leite PF, Danilovic A, Moriel P, Dantas K, Marklund S, et al. (2003) Sustained decrease in superoxide dismutase activity underlies constrictive remodeling after balloon injury in rabbits. Arterioscler Thromb Vasc Biol 23: 2197-2202.
7. Laukkanen MO, Leppanen P, Turunen P, Tuomisto T, Naarala J, et al. (2001) EC-SOD gene therapy reduces paracetamol-induced liver damage in mice. J Gene Med 3: 321-325.
8. Laurila JP, Castellone MD, Curcio A, Laatikainen LE, Haaparanta-Solin M, et al. (2009) Extracellular superoxide dismutase is a growth regulatory mediator of tissue injury recovery. Mol Ther 17: 448-454.
9. Ozumi K, Tasaki H, Takatsu H, Nakata S, Morishita T, et al. (2005) Extracellular superoxide dismutase overexpression reduces cuff-induced arterial neointimal formation. Atherosclerosis 181: 55-62.
10. Qin Z, Reszka KJ, Fukai T, Weintraub NL, (2008) Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD. Transl Res 151: 68-78.
11. Folz RJ, Abushamaa AM, Suliman HB, (1999) Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest 103: 1055-1066.
12. Brandes RP, Weissmann N, Schroder K, (2010) NADPH oxidases in cardiovascular disease. Free Radic Biol Med 49: 687-706.
13. Younes M, Schoenberg MH, Jung H, Fredholm BB, Haglund U, et al. (1984) Oxidative tissue damage following regional intestinal ischemia and reperfusion in the cat. Res Exp Med (Berl) 184: 259-264.
14. Laurila JP, Laatikainen LE, Castellone MD, Laukkanen MO, (2009) SOD3 reduces inflammatory cell migration by regulating adhesion molecule and cytokine expression. PLoS One 4: e5786.
15. Yordy JS, Muise-Helmericks RC, (2000) Signal transduction and the Ets family of transcription factors. Oncogene 19: 6503-6513.
16. Wasylyk B, Hagman J, Gutierrez-Hartmann A, (1998) Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sci 23: 213-216.
17. Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, et al. (2008) ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 10: 138-148.
18. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
19. Hu Y, Wang X, Zeng L, Cai DY, Sabapathy K, et al. (2005) ERK phosphorylates p66shcA on Ser36 and subsequently regulates p27kip1 expression via the Akt-FOXO3a pathway: implication of p27kip1 in cell response to oxidative stress. Mol Biol Cell 16: 3705-3718.
20. van der Horst A, Burgering BM, (2007) Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 8: 440-450.
21. Wang K, Li PF, (2010) Foxo3a regulates apoptosis by negatively targeting miR-21. J Biol Chem 285: 16958-16966.
22. Essafi A, Fernandez de Mattos S, Hassen YA, Soeiro I, Mufti GJ, et al. (2005) Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 24: 2317-2329.
23. Balmanno K, Cook SJ, (2009) Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ 16: 368-377.
24. Qi XJ, Wildey GM, Howe PH, (2006) Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function. J Biol Chem 281: 813-823.
25. Karlsson K, Sandstrom J, Edlund A, Marklund SL, (1994) Turnover of extracellular-superoxide dismutase in tissues. Lab Invest 70: 705-710.
26. Gao Y, Ordas R, Klein JD, Price SR, (2008) Regulation of caspase-3 activity by insulin in skeletal muscle cells involves both PI3-kinase and MEK-1/2. J Appl Physiol 105: 1772-1778.
27. Allan LA, Morrice N, Brady S, Magee G, Pathak S, et al. (2003) Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biol 5: 647-654.
28. Biswas SC, Greene LA, (2002) Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation. J Biol Chem 277: 49511-49516.
29. Liu JW, Chandra D, Rudd MD, Butler AP, Pallotta V, et al. (2005) Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS. Oncogene 24: 2020-2031.
30. Lee HY, You HJ, Won JY, Youn SW, Cho HJ, et al. (2008) Forkhead factor, FOXO3a, induces apoptosis of endothelial cells through activation of matrix metalloproteinases. Arterioscler Thromb Vasc Biol 28: 302-308.
31. Furukawa-Hibi Y, Kobayashi Y, Chen C, Motoyama N, (2005) FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. Antioxid Redox Signal 7: 752-760.
32. Lei H, Quelle FW, (2009) FOXO transcription factors enforce cell cycle checkpoints and promote survival of hematopoietic cells after DNA damage. Mol Cancer Res 7: 1294-1303.
33. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, et al. (2002) Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419: 316-321.
34. Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, et al. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128: 325-339.
35. Huang H, Tindall DJ, (2007) Dynamic FoxO transcription factors. J Cell Sci 120: 2479-2487.